Try our mobile app

Published: 2022-10-27 00:00:00 ET
<<<  go to NATI company page
HTTP/1.1 200 OK HTTP/1.1 200 OK X-Crawlera-Slave: 23.229.72.18:8800 X-Crawlera-Version: 1.60.1 accept-ranges: bytes content-type: text/html last-modified: Thu, 27 Oct 2022 20:06:04 GMT server: AmazonS3 x-amz-id-2: +i2Y+TM8x6gQocZ4OSIQl9Lz0OlvVRDgHNuLE4Vb3oJhvV4zlGuTRqOFXeB07NE7b3bH439d72I= x-amz-meta-mode: 33188 x-amz-meta-s3cmd-attrs: uid:504/gname:fitrprnt/uname:fitrprnt/gid:504/mode:33184/mtime:1666901160/atime:1666901160/md5:7dc114e97718629e61a19257941d62fb/ctime:1666901161 x-amz-replication-status: COMPLETED x-amz-request-id: 1E6GV0C84Y1CJ5AZ x-amz-version-id: JC9GmhfMI3aUzrW8fDD7vMoYf2dJasdc x-content-type-options: nosniff x-frame-options: SAMEORIGIN x-xss-protection: 1; mode=block x-akamai-transformed: 9 22854 0 pmb=mTOE,2 expires: Wed, 05 Apr 2023 15:18:20 GMT cache-control: max-age=0, no-cache, no-store pragma: no-cache date: Wed, 05 Apr 2023 15:18:20 GMT vary: Accept-Encoding akamai-x-true-ttl: -1 strict-transport-security: max-age=31536000 ; includeSubDomains ; preload set-cookie: ak_bmsc=0D83B02469E50889ADD7013CDDBF712A~000000000000000000000000000000~YAAQXA/QF1i8WjaHAQAAM1P/URPla69qOX4aMVkCy4gNiLRm3pBUtiWvBJXPoI2SO1pKAcMnr8mIQjTWLlkDPE7Uwu6bHPWAWe8Y798arMFLql6ulv3dY5mnUVZSHp4AEMKz1Tl4Jfjp8RSeXUsXSbpE1YRXeE8dACgyC0Wu42EuRG/E0PFHydAWWoYLKOYkZDspM41djev4tDIGh4OfibMAAfM18NRrGPnknHdhFuoyR7CMlq/upGbDBjBeZcMhjCAE2C9vmqIpwFJvnUzoJeajCvPxPk1jr7EJySaPJOtVZnfjwYgwjtc6QI7ZWW4XBbbBhDAeN7stm+8v2/itmdWv+E1Rr5woLbNSedhgSIGngrOiI1kv0z5ad0HS2RaswDqUaJx3; Domain=.sec.gov; Path=/; Expires=Wed, 05 Apr 2023 17:18:19 GMT; Max-Age=7199; HttpOnly set-cookie: bm_mi=44791EDFC6795CAAE2203AF0D7BF1EA4~YAAQXA/QF1m8WjaHAQAAM1P/UROfyAIPKLiLUIHC8SHYy8BmbS+U9rvFIw1NBT++Qi2WUH/ks74SHCQjYee61Yvuihn5t2tkhF5gIie1wHG6dWrtLnq9KtMU1aGb1I008XdP4I68lkwPD2ncqTrogYFJgABKWQMBaapL1CQaF7dT8bgweVTiKEfFvxa+JtytzYKlYyQHy9ai1HvBfwOd55g7vllvA832IGW67sPnbH/GPTpj4vyZnUvxvbC490as6jdVwZvOOnUzSSkCrdRjSB1pYYGvTSCTQHryeYOPYO6DM50Iab9j+JfahYfCxLIcQjwRfHhb60ZoMDaumFHp3Vi8HkROb95DuWN4NOhbAcan2Z58PexHAzhUlEPaCQCXd/MN6hHwKw==~1; Domain=.sec.gov; Path=/; Expires=Wed, 05 Apr 2023 15:18:20 GMT; Max-Age=0; Secure Transfer-Encoding: chunked Proxy-Connection: close Connection: close EX-99.1 2 exhibit99_1.htm EXHIBIT 99.1
Contact:
 
Marissa Vidaurri
   
Head of Investor Relations
   
(512) 683-5215


NI Reports Record Third Quarter Revenue, up 17 Percent YOY
Operating margin up more than 100 basis points YTD

Q3 2022 Summary

Record GAAP revenue of $428 million, up 17 percent year over year

Record orders for a third quarter, up 12 percent year over year

Strong diluted GAAP EPS of $0.47 and diluted non-GAAP EPS of $0.53

Cash and cash equivalents of $149 million as of September 30, 2022

AUSTIN, Texas - October 27, 2022 - National Instruments Corporation (Nasdaq: NATI) today announced Q3 2022 revenue of $428 million, up 17 percent year over year, an all-time quarterly record.

In Q3 2022, the total value of the company's orders was up 12 percent year over year. For Q3, year over year orders were up 16 percent in the Americas, down 1 percent in APAC, and up 23 percent in EMEA.

In Q3, GAAP gross margin was 66 percent and non-GAAP gross margin was 70 percent. Total GAAP operating expenses were $237 million and non-GAAP operating expenses were $208 million. GAAP operating income for Q3 was $80 million with non-GAAP operating income of $92 million. In Q3, GAAP operating margin was 19 percent with non-GAAP operating margin of 21 percent.

GAAP net income for Q3 was $62 million and non-GAAP net income was $71 million, with GAAP diluted EPS of $0.47 and non-GAAP diluted EPS of $0.53. GAAP net income includes $26 million of gains, net of tax, related to real estate sales that were completed during the third quarter of 2022.

“We achieved very strong performance in the third quarter with record orders, revenue and non-GAAP EPS for a third consecutive quarter." said Eric Starkloff, NI President and CEO. “The initiatives that we’ve executed since 2017 have transformed NI into a company with higher growth, better profitability, and lower cyclicality. We believe these strategic shifts position us to meet our three year plan for growth and margin expansion."

“We planned ahead and are taking action in anticipation of a semiconductor downturn and the impact of a weaker macro economy. Looking ahead, we will continue to sharpen our focus on making intentional investments for growth, pivoting to new customer opportunities, and on continuing to increase scale and leverage across our business,” said Karen Rapp, NI CFO. "Through disciplined cost management, we remain focused on delivering on our commitment to increase non-GAAP operating margin by 100 basis points in 2022.”

As of September 30, 2022, NI had $149 million in cash and cash equivalents. During the third quarter, NI paid $37 million in dividends and repurchased approximately 2 million shares of its common stock at an average price of $40.25 per share. The NI Board of Directors approved a quarterly dividend of $0.28 per share payable on November 28, 2022, to stockholders of record as of the close of business on November 7, 2022.
NI's non-GAAP results exclude, as applicable, the impact of purchase accounting fair value adjustments, stock-based compensation, amortization of acquisition-related intangibles, acquisition-related transaction and integration costs, taxes levied on the transfer of acquired intellectual property, foreign exchange loss on acquisitions, restructuring charges, tax reform charges, disposal gains on properties and buildings and related charitable contributions, tax effects related to businesses held for sale, gain on sale of businesses, and capitalization and amortization of internally developed software costs. Reconciliations of the NI's GAAP and non-GAAP results are included as part of this news release.

YTD 2022 Summary

Record GAAP revenue of $1,209 million, up 15 percent year over year

Record orders, up 18 percent year over year

Strong diluted GAAP EPS of $0.75, up 103 percent year over year and record diluted non-GAAP EPS of $1.30, up 20 percent year over year

Guidance

Q4 GAAP revenue to be in the range of $435 million to $465 million, up 7 percent year over year at the midpoint

GAAP diluted EPS to be in the range of $0.22 to $0.36 for Q4, down 3 percent year over year at the midpoint

Non-GAAP diluted EPS expected to be in the range of $0.54 to $0.68, up 2 percent year over year at the midpoint

Conference Call Information

Today, NI management will host a call with the investment community to discuss the company's financial performance in the third quarter. Investors can listen to the Q3 2022 earnings conference call beginning at 4:00 p.m. CT today. This event will be webcast in listen-only mode. Listeners may log on to the call at http://www.ni.com/investor-relations under the “Events and Presentations” section and select “Q3 2022 NATI Earnings Conference Call” to participate. The webcast will remain on the company site for 90 days.

Non-GAAP Presentation

To supplement NI’s financial statements presented on a GAAP basis, NI has provided non-GAAP financial information, including non-GAAP revenue or net sales, gross profit, gross margin, operating expenses, operating income, operating margin, provision for income taxes, net income, net margin and diluted EPS and non-GAAP guidance for diluted EPS. A reconciliation of the adjustments to GAAP results is included in the tables below. Additionally, certain non-GAAP financial measures presented on a forward-looking basis, such as non-GAAP operating margin, were not reconciled to the comparable GAAP financial measures because the reconciliation could not be performed without unreasonable efforts due to the unpredictability of the amounts and timing of events affecting the items we exclude from non-GAAP measures. Non-GAAP financial information is not meant as a substitute for GAAP results, but is included because management believes such information is useful to our investors for informational and comparative purposes. In addition, certain non-GAAP financial information is used internally by management to evaluate and manage the company. The non-GAAP financial information used by NI may differ from that used by other companies. These non-GAAP measures should be considered in addition to, and not as a substitute for, the results prepared in accordance with GAAP.

Forward-Looking Statements

This release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 including without limitation those statements about our expectations of accelerating growth and progress to meet or exceed our financial targets and long-term financial model, our continued momentum across regions and business units, our opportunities to drive growth, profitability and efficiency in our business, confidence in our strategy and the strategic changes made to our business, our ability to successfully integrate acquisitions and execute our growth strategy, our ability to turn backlog to revenue, our ability to drive customer demand through focus on high growth opportunities, the impacts of war in Europe, supply chain constraints and software licensing model transition on our financial results, and our guidance and expectations for our Q4 2022 revenue, diluted EPS and non-GAAP diluted EPS, and future operating expenses, backlog, lead times, gross margin, operating margin and tax rate. These statements are subject to a number of risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements.  Risks and uncertainties include without limitation: the global shortage of key components; effect of the global economic and geopolitical conditions; our international operations and foreign economies; adverse public health matters, including epidemics and pandemics such as the COVID-19 pandemic; our ability to effectively manage our partners and distribution channels; interruptions in our technology systems or cyber-attacks on our systems; the dependency of our product revenue on certain industries and the risk of contractions in such industries; concentration of credit risk and uncertain conditions in the global financial markets; our ability to compete in markets that are highly competitive; our ability to release successful new products or achieve expected returns; the risk that our manufacturing capacity and a substantial majority of our warehousing and distribution capacity are located outside of the U.S.; our dependence on key suppliers and distributors; longer delivery lead times from our suppliers; risk of product liability claims; dependence on our proprietary rights and risks of intellectual property litigation; the continued service of key management, technical personnel and operational employees; our ability to comply with environmental laws and associated costs; our ability to maintain our website; the risks of bugs, vulnerabilities, errors or design flaws in our products; our restructuring activities; our exposure to large orders; our shift to more system orders; our ability to effectively manage our operating expenses and meet budget; fluctuations in our quarterly results due to factors outside of our control; our outstanding debt; seasonal variation in our revenues; our ability to comply with laws and regulations; changes in tax rates and exposure to additional tax liabilities; our ability to make certain acquisitions or dispositions, integrate the companies we acquire or separate the companies we sold and/or enter into strategic relationships; risks related to currency fluctuations; and provisions in charter documents and Delaware law that delay or prevent our acquisition.  In addition, our ability to declare and/or pay declared dividends is subject to compliance with the terms of our existing credit agreement. The company directs readers to its Form 10-K for the year ended December 31, 2021, and the other documents it files with the SEC for other risks associated with the company’s future performance. These documents contain and identify important factors that could cause our actual results to differ materially from those contained in our forward-looking statements.  All information in this release is as of the date above. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company’s expectations.

About NI

At NI, we bring together people, ideas and technology so forward thinkers and creative problem solvers can take on humanity’s biggest challenges. From data and automation to research and validation, we provide the tailored, software-connected systems engineers and enterprises need to Engineer Ambitiously™ every day.

National Instruments, NI and ni.com and Engineer Ambitiously are trademarks of National Instruments Corporation. Other product and company names listed are trademarks or trade names of their respective companies. (NATI-F)



National Instruments
 
Condensed Consolidated Balance Sheets
 
(in thousands)
 
   
September 30,
   
December 31,
 
   
2022
   
2021
 
   
(unaudited)
       
Assets
           
Cash and cash equivalents
 
$
149,002
   
$
211,106
 
Accounts receivable, net
   
380,792
     
341,275
 
Inventories, net
   
373,544
     
289,243
 
Prepaid expenses and other current assets
   
144,145
     
89,925
 
Total current assets
   
1,047,483
     
931,549
 
Property and equipment, net
   
254,127
     
253,668
 
Goodwill
   
593,148
     
575,992
 
Intangible assets, net
   
219,730
     
220,418
 
Operating lease right-of-use assets
   
59,906
     
58,641
 
Other long-term assets
   
71,140
     
74,717
 
Total assets
 
$
2,245,534
   
$
2,114,985
 
                 
Liabilities and Stockholders' Equity
               
Accounts payable and accrued expenses
 
$
96,848
   
$
83,218
 
Accrued compensation
   
61,166
     
111,261
 
Deferred revenue - current
   
118,257
     
137,818
 
Operating lease liabilities - current
   
13,288
     
13,137
 
Other taxes payable
   
61,002
     
59,109
 
Debt, current
   
25,000
     
 
Other current liabilities
   
52,079
     
40,671
 
Total current liabilities
   
427,640
     
445,214
 
Deferred income taxes
   
13,725
     
14,249
 
Income tax payable - non-current
   
40,646
     
54,195
 
Deferred revenue - non-current
   
50,177
     
32,822
 
Operating lease liabilities - non-current
   
32,027
     
30,468
 
Debt - non-current
   
542,768
     
300,000
 
Other long-term liabilities
   
15,066
     
14,340
 
Total liabilities
 
$
1,122,049
   
$
891,288
 
                 
Stockholders' equity:
               
Common stock
   
1,306
     
1,323
 
Additional paid-in capital
   
1,183,329
     
1,129,647
 
Retained earnings
   
(18,135
)
   
112,858
 
Accumulated other comprehensive loss
   
(43,015
)
   
(20,131
)
Total stockholders' equity
   
1,123,485
     
1,223,697
 
Total liabilities and stockholders' equity
 
$
2,245,534
   
$
2,114,985
 




National Instruments
 
Condensed Consolidated Statements of Income
 
(in thousands, except per share data, unaudited)
 
                   
   
Three Months Ended
   
Nine Months Ended
 
   
September 30,
   
September 30,
 
   
2022
   
2021
   
2022
   
2021
 
                         
Net sales:
                       
Product
 
$
389,620
   
$
325,724
   
$
1,088,110
   
$
927,307
 
Software maintenance
   
38,308
     
41,438
     
120,589
     
121,733
 
Total net sales
   
427,928
     
367,162
     
1,208,699
     
1,049,040
 
                                 
Cost of sales:
                               
Product
   
139,823
     
99,072
     
378,154
     
286,485
 
Software maintenance
   
3,879
     
3,643
     
12,249
     
10,882
 
Total cost of sales
   
143,702
     
102,715
     
390,403
     
297,367
 
                                 
Gross profit
   
284,226
     
264,447
     
818,296
     
751,673
 
     
66.4%

   
72.0%

   
67.7%

   
71.7%

Operating expenses:
                               
Sales and marketing
   
119,951
     
117,065
     
365,015
     
345,048
 
Research and development
   
82,861
     
82,165
     
250,610
     
243,685
 
General and administrative
   
34,617
     
31,037
     
104,569
     
94,672
 
Total operating expenses
   
237,429
     
230,267
     
720,194
     
683,405
 
Gain on sale of assets
   
33,636
     
     
33,636
     
 
Operating income
   
80,433
     
34,180
     
131,738
     
68,268
 
Other expense
   
(5,150
)
   
(1,820
)
   
(8,622
)
   
(9,851
)
Income before income taxes
   
75,283
     
32,360
     
123,116
     
58,417
 
Provision for income taxes
   
13,376
     
5,183
     
23,539
     
9,438
 
Net income
 
$
61,907
   
$
27,177
   
$
99,577
   
$
48,979
 
                                 
Basic earnings per share
 
$
0.47
   
$
0.20
   
$
0.75
   
$
0.37
 
Diluted earnings per share
 
$
0.47
   
$
0.20
   
$
0.75
   
$
0.37
 
                                 
Weighted average shares outstanding -
                               
Basic
   
132,044
     
133,031
     
132,040
     
132,657
 
Diluted
   
132,581
     
133,686
     
133,001
     
133,829
 
                                 
Dividends declared per share
 
$
0.28
   
$
0.27
   
$
0.84
   
$
0.81
 



   
Condensed Consolidated Statements of Cash Flows
 
(in thousands, unaudited)
 
   
Nine Months Ended September 30,
 
   
2022
   
2021
 
       
Cash flow from operating activities:
           
Net income
 
$
99,577
   
$
48,979
 
Adjustments to reconcile net income to net cash provided by operating activities:
               
Disposal gains on sale of assets
   
(33,636
)
   
 
Depreciation and amortization
   
68,828
     
73,418
 
Stock-based compensation
   
60,843
     
56,064
 
Loss from equity-method investees
   
(483
)
   
5,082
 
Deferred income taxes
   
928
     
(2,030
)
Net change in operating assets and liabilities
   
(204,987
)
   
(95,477
)
Net cash (used in) provided by operating activities
   
(8,930
)
   
86,036
 
                 
Cash flow from investing activities:
               
Acquisitions, net of cash received
   
(72,802
)
   
(19,784
)
Capital expenditures
   
(39,193
)
   
(26,147
)
Proceeds from sale of assets
   
40,987
     
 
Capitalization of internally developed software
   
(388
)
   
(1,246
)
Additions to other intangibles
   
(3,165
)
   
(2,317
)
Acquisitions of equity-method investments
   
     
(15,753
)
Sales and maturities of short-term investments
   
     
59,714
 
Net cash used in  investing activities
   
(74,561
)
   
(5,533
)
                 
Cash flow from financing activities:
               
Proceeds from revolving loan facility
   
268,000
     
100,000
 
Payments on revolving loan facility
   
(498,000
)
   
 
Proceeds from term loan
   
500,000
     
 
Payments on term loan
   
     
(98,750
)
Debt issuance costs
   
(2,348
)
   
(1,993
)
Proceeds from issuance of common stock
   
25,444
     
25,438
 
Repurchase of common stock
   
(151,831
)
   
(25,000
)
Dividends paid
   
(111,161
)
   
(107,397
)
Net cash provided by (used in) financing activities
   
30,104
     
(107,702
)
                 
Impact of changes in exchange rates on cash
   
(8,717
)
   
(2,336
)
                 
Net change in cash and cash equivalents
   
(62,104
)
   
(29,535
)
Cash and cash equivalents at beginning of period
   
211,106
     
260,232
 
Cash and cash equivalents at end of period
 
$
149,002
   
$
230,697
 



The following tables provide details with respect to the amount of GAAP charges related to stock-based compensation, amortization of acquisition-related intangibles and fair value adjustments, acquisition-related transaction and integration costs, capitalization and amortization of internally developed software costs, restructuring charges, gains on sale of assets, and other that were recorded in the line items indicated below (unaudited) (in thousands)
 
                         
   
Three Months Ended
   
Nine Months Ended
 
   
September 30,
   
September 30,
 
                         
   
2022
   
2021
   
2022
   
2021
 
Stock-based compensation
                       
Cost of sales
 
$
1,300
   
$
1,183
   
$
3,775
   
$
3,487
 
Sales and marketing
   
7,148
     
6,332
     
21,439
     
18,949
 
Research and development
   
6,163
     
5,811
     
18,522
     
17,704
 
General and administrative
   
5,429
     
5,530
     
17,107
     
16,050
 
Provision for income taxes
   
(3,039
)
   
(2,798
)
   
(7,687
)
   
(10,036
)
Total
 
$
17,001
   
$
16,058
   
$
53,156
   
$
46,154
 
                                 
Amortization of acquisition-related intangibles and fair value adjustments
                               
Net sales
 
$
371
   
$
421
   
$
1,114
   
$
1,971
 
Cost of sales
   
6,806
     
4,194
     
17,025
     
12,691
 
Sales and marketing
   
5,712
     
2,331
     
17,423
     
6,859
 
Research and development
   
     
     
(320
)
   
 
Other expense (income)
   
482
     
529
     
1,500
     
1,476
 
Provision for income taxes
   
(2,272
)
   
(917
)
   
(5,802
)
   
(2,870
)
Total
 
$
11,099
   
$
6,558
   
$
30,940
   
$
20,127
 
                                 
Acquisition transaction and integration costs, restructuring charges, and other
                               
Net sales
 
$
(411
)
 
$
   
$
(411
)
 
$
 
Cost of sales
   
6,604
     
(7
)
   
8,548
     
(50
)
Sales and marketing
   
2,819
     
584
     
5,464
     
6,071
 
Research and development
   
453
     
386
     
1,555
     
1,422
 
General and administrative
   
1,461
     
850
     
4,479
     
7,388
 
Gain on sale of assets
   
(33,636
)
   
     
(33,636
)
   
 
Other expense (income)
   
(3,153
)
   
316
     
(5,285
)
   
4,322
 
Provision for income taxes
   
5,850
     
(238
)
   
4,494
     
(3,701
)
Total
 
$
(20,013
)
 
$
1,891
   
$
(14,792
)
 
$
15,452
 
                                 
(Capitalization) and amortization of internally developed software costs
                               
Cost of sales
 
$
1,160
   
$
5,532
   
$
5,090
   
$
18,633
 
Research and development
   
(202
)
   
(525
)
   
(388
)
   
(1,246
)
Provision for income taxes
   
(216
)
   
(1,192
)
   
(1,059
)
   
(3,792
)
Total
 
$
742
   
$
3,815
   
$
3,643
   
$
13,595
 



National Instruments
 
Reconciliation of GAAP to Non-GAAP Measures
 
(in thousands, unaudited)
 
                         
   
Three Months Ended
   
Nine Months Ended
 
   
September 30,
   
September 30,
 
   
2022
   
2021
   
2022
   
2021
 
                         
Reconciliation of Gross Profit to Non-GAAP Gross Profit
             
Gross profit, as reported
 
$
284,226
   
$
264,447
   
$
818,296
   
$
751,673
 
Stock-based compensation
   
1,300
     
1,183
     
3,775
     
3,487
 
Amortization of acquisition-related intangibles and fair value adjustments
   
7,177
     
4,615
     
18,139
     
14,662
 
Acquisition transaction and integration costs, restructuring charges and other
   
6,193
     
(7
)
   
8,137
     
(50
)
Amortization of internally developed software costs
   
1,160
     
5,532
     
5,090
     
18,633
 
Non-GAAP gross profit
 
$
300,056
   
$
275,770
   
$
853,437
   
$
788,405
 
Non-GAAP gross margin
   
70.1%

   
75.0%

   
70.6%

   
75.0%

                                 
Reconciliation of Operating Expenses to Non-GAAP Operating Expenses
                 
Operating expenses, as reported
 
$
237,429
   
$
230,267
   
$
720,194
   
$
683,405
 
Stock-based compensation
   
(18,740
)
   
(17,673
)
   
(57,068
)
   
(52,703
)
Amortization of acquisition-related intangibles and fair value adjustments
   
(5,712
)
   
(2,331
)
   
(17,103
)
   
(6,859
)
Acquisition transaction and integration costs, restructuring charges and other
   
(4,733
)
   
(1,820
)
   
(11,498
)
   
(14,881
)
Capitalization of internally developed software costs
   
202
     
525
     
388
     
1,246
 
Non-GAAP operating expenses
 
$
208,446
   
$
208,968
   
$
634,913
   
$
610,208
 
                                 
Reconciliation of Operating Income to Non-GAAP Operating Income(1)
                 
Operating income, as reported
 
$
80,433
   
$
34,180
   
$
131,738
   
$
68,268
 
Stock-based compensation
   
20,040
     
18,856
     
60,843
     
56,190
 
Amortization of acquisition-related intangibles and fair value adjustments
   
12,889
     
6,946
     
35,242
     
21,521
 
Acquisition transaction and integration costs, restructuring charges and other
   
10,926
     
1,813
     
19,635
     
14,831
 
Net amortization of internally developed software costs
   
958
     
5,007
     
4,702
     
17,387
 
Gain on sale of assets
   
(33,636
)
   
     
(33,636
)
   
 
Non-GAAP operating income
 
$
91,610
   
$
66,802
   
$
218,524
   
$
178,197
 
Non-GAAP operating margin
   
21.4%

   
18.2%

   
18.1%

   
17.0%

                                 
Reconciliation of Provision for income taxes to Non-GAAP Provision for income taxes(2)
                 
Provision for income taxes, as reported
 
$
13,376
   
$
5,183
   
$
23,539
   
$
9,438
 
Stock-based compensation
   
3,039
     
2,798
     
7,687
     
10,036
 
Amortization of acquisition-related intangibles and fair value adjustments
   
2,272
     
917
     
5,802
     
2,870
 
Acquisition transaction and integration costs, restructuring charges and other
   
1,967
     
238
     
3,323
     
3,701
 
Net amortization of internally developed software costs
   
216
     
1,192
     
1,059
     
3,792
 
Gain on sale of assets
   
(7,817
)
   
     
(7,817
)
   
 
Non-GAAP provision for income taxes(2)
 
$
13,053
   
$
10,328
   
$
33,593
   
$
29,837
 
(1): During the third quarter of 2022, the company recognized a gain of $34 million related to the sale of land and office buildings, presented within "Gain on sale of assets".
 
(2): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.
 



Reconciliation of GAAP Net Income and Diluted EPS to Non-GAAP Net Income and Non-GAAP Diluted EPS
 
(in thousands, except per share data, unaudited)
 
                         
   
Three Months Ended
   
Nine Months Ended
 
   
September 30,
   
September 30,
 
   
2022
   
2021
   
2022
   
2021
 
                         
Net income, as reported
 
$
61,907
   
$
27,177
   
$
99,577
   
$
48,979
 
Adjustments to reconcile net income to non-GAAP net income:
                               
  Stock-based compensation
   
20,040
     
18,856
     
60,843
     
56,190
 
Amortization of acquisition-related intangibles and fair value adjustments
   
13,371
     
7,475
     
36,742
     
22,997
 
Acquisition transaction and integration costs, restructuring charges and other
   
7,773
     
2,129
     
14,350
     
19,153
 
Net amortization of internally developed software costs
   
958
     
5,007
     
4,702
     
17,387
 
Gain on sale of assets(1)
   
(33,636
)
   
     
(33,636
)
   
 
Income tax effects and adjustments(2)
   
323
     
(5,145
)
   
(10,054
)
   
(20,399
)
Non-GAAP net income
 
$
70,736
   
$
55,499
   
$
172,524
   
$
144,307
 
Non-GAAP net margin
   
16.5%

   
15.1%

   
14.3%

   
13.7%

   
Diluted EPS, as reported
 
$
0.47
   
$
0.20
   
$
0.75
   
$
0.37
 
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS
                               
 Stock-based compensation
   
0.15
     
0.14
     
0.46
     
0.42
 
Amortization of acquisition-related intangibles and fair value adjustments
   
0.10
     
0.06
     
0.28
     
0.17
 
Acquisition transaction and integration costs, restructuring charges and other
   
0.05
     
0.02
     
0.11
     
0.14
 
Net amortization of internally developed software costs
   
0.01
     
0.04
     
0.03
     
0.13
 
Gain on sale of assets(1)
   
(0.25
)
   
     
(0.25
)
   
 
Income tax effects and adjustments(2)
   
     
(0.04
)
   
(0.08
)
   
(0.15
)
Non-GAAP diluted EPS
 
$
0.53
   
$
0.42
   
$
1.30
   
$
1.08
 
(1): During the third quarter of 2022, the company recognized a gain of $34 million related to the sale of land and office buildings, presented within "Gain on sale of assets".
 
(2): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.
 
Weighted average shares outstanding - Diluted
   
132,581
     
133,686
     
133,001
     
133,829
 



Reconciliation of GAAP Diluted EPS to Non-GAAP Diluted EPS Guidance
 
(unaudited)
 
   
Three Months Ended
 
   
December 31, 2022
 
             
   
Low
   
High
 
GAAP Diluted EPS, guidance
 
$
0.22
   
$
0.36
 
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS:
               
Stock-based compensation
   
0.15
     
0.15
 
Amortization of acquisition-related intangibles and fair value adjustments
   
0.10
     
0.10
 
Acquisition transaction and integration costs, restructuring charges, and other(1)
   
0.13
     
0.13
 
Income tax effects and adjustments(2)
   
(0.06
)
   
(0.06
)
Non-GAAP Diluted EPS, guidance
 
$
0.54
   
$
0.68
 
(1): Includes $10 million of pre-tax charitable contribution using a portion of the proceeds received from real estate sales completed in the third quarter of 2022.
 
(2): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.